Celator Pharma Cmn (CPXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,152 | -2,030 | -14,150 |
| Depreciation Amortization | 172 | 86 | 440 |
| Accounts receivable | 1,082 | 953 | 0 |
| Accounts payable and accrued liabilities | 115 | -313 | 0 |
| Other Working Capital | 971 | 625 | -1,630 |
| Other Operating Activity | -750 | -259 | 740 |
| Operating Cash Flow | $-2,562 | $-937 | $-14,600 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -13 | -10 | -90 |
| Investing Cash Flow | $-13 | $-10 | $-90 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 1,077 | 77 | 0 |
| Other Financing Activity | 0 | 0 | 7,520 |
| Financing Cash Flow | $1,077 | $77 | $7,520 |
| Exchange Rate Effect | 0 | -2 | 1 |
| Beginning Cash Position | 3,227 | 3,227 | 10,390 |
| End Cash Position | 1,730 | 2,356 | 3,220 |
| Net Cash Flow | $-1,497 | $-871 | $-7,170 |
| Free Cash Flow | |||
| Operating Cash Flow | -2,562 | -937 | -14,600 |
| Capital Expenditure | -18 | -15 | 0 |
| Free Cash Flow | -2,579 | -952 | -14,600 |